1. Home
  2. TOI vs PHGE Comparison

TOI vs PHGE Comparison

Compare TOI & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOI
  • PHGE
  • Stock Information
  • Founded
  • TOI 2007
  • PHGE 2015
  • Country
  • TOI United States
  • PHGE Israel
  • Employees
  • TOI N/A
  • PHGE N/A
  • Industry
  • TOI Medical/Nursing Services
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOI Health Care
  • PHGE Health Care
  • Exchange
  • TOI Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • TOI 22.7M
  • PHGE 26.5M
  • IPO Year
  • TOI N/A
  • PHGE N/A
  • Fundamental
  • Price
  • TOI $0.32
  • PHGE $0.92
  • Analyst Decision
  • TOI Strong Buy
  • PHGE Strong Buy
  • Analyst Count
  • TOI 1
  • PHGE 2
  • Target Price
  • TOI $2.50
  • PHGE $22.50
  • AVG Volume (30 Days)
  • TOI 73.8K
  • PHGE 48.4K
  • Earning Date
  • TOI 11-06-2024
  • PHGE 11-12-2024
  • Dividend Yield
  • TOI N/A
  • PHGE N/A
  • EPS Growth
  • TOI N/A
  • PHGE N/A
  • EPS
  • TOI N/A
  • PHGE N/A
  • Revenue
  • TOI $361,067,000.00
  • PHGE N/A
  • Revenue This Year
  • TOI $29.17
  • PHGE N/A
  • Revenue Next Year
  • TOI $16.43
  • PHGE N/A
  • P/E Ratio
  • TOI N/A
  • PHGE N/A
  • Revenue Growth
  • TOI 23.31
  • PHGE N/A
  • 52 Week Low
  • TOI $0.27
  • PHGE $0.88
  • 52 Week High
  • TOI $2.66
  • PHGE $8.55
  • Technical
  • Relative Strength Index (RSI)
  • TOI 47.54
  • PHGE 29.22
  • Support Level
  • TOI $0.29
  • PHGE $0.88
  • Resistance Level
  • TOI $0.34
  • PHGE $1.15
  • Average True Range (ATR)
  • TOI 0.02
  • PHGE 0.07
  • MACD
  • TOI 0.01
  • PHGE 0.02
  • Stochastic Oscillator
  • TOI 65.42
  • PHGE 13.54

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

Share on Social Networks: